Testosterone: role in men's health — functions, regulation,

Testosterone: role in male health

Contemporary culture treats testosterone as a symbol: energy, initiative, power, “masculinity” in numerical form. It is a reassuring idea because it seems to offer a simple lever over complex experiences: fatigue, desire, motivation, body composition, confidence. But physiology rarely offers switches.

Testosterone is an integrated signal of state: it reflects how sustainable the body considers it to invest in androgen-dependent functions (reproduction, maintenance of specific tissues, erythropoiesis, part of metabolic regulation) within a context shaped by sleep, available energy, inflammation, stress, and disease burden. It does not by itself “explain” subjective life. It can contribute, it can be part of a picture, it can be a marker. But it is almost never a single narrative.

This distinction — endocrinology as a system of constraints, not as fuel — changes the way symptoms are read and test results are interpreted. It also changes the kind of caution needed when considering interventions: because shifting a hormonal axis is not the same as improving everything; it often means shifting trade-offs.

It is not a switch: testosterone as a signal of state, not as “fuel”

There is a persistent tension between imagery and biology. In the popular imagination, testosterone is a substance that “adds”: grit, assertiveness, vigor. In biology, it is a variable regulated by feedback, transport, peripheral conversions, and tissue sensitivity. The point is not to deny that it matters: it is to understand how it matters and where it stops being a useful explanation.

Physiologically, testosterone participates in functions of major importance: - Development and maintenance of androgen-dependent tissues, with effects that also depend on local metabolism (for example, conversion to DHT in certain tissues). - Spermatogenesis, which is not simply “testosterone and that’s it”: it requires the architecture of the axis and the coordinated action of LH and FSH on Leydig and Sertoli cells. - Muscle mass and strength, through modulation of protein synthesis and turnover; here too, training context, energy intake, and recovery matter. - Bone density, often also mediated by estradiol derived from aromatization, a detail that complicates the “more testosterone = stronger bones” narrative. - Erythropoiesis, with the potential for increased hematocrit: whether this is an advantage or a risk depends on the level and the individual profile. - Fat distribution and insulin sensitivity, in a non-linear way: the direction can change depending on visceral adiposity, inflammation, and lifestyle.

On the subjective side, many widely repeated associations are more indirect than people assume. “Aggressiveness,” charisma, or social success are constructs mediated by context, sleep, stress, dopamine, self-esteem, vascular health, and relationship quality. Testosterone may be permissive (a biological ground that makes a certain response more likely), but it is rarely deterministic.

And every attempt to “shift” it has possible costs: polycythemia/high hematocrit, acne, worsening of androgenetic alopecia in predisposed individuals, changes in lipid profile, and above all suppression of fertility if exogenous testosterone is introduced. That is why a mature approach does not ask “how can I raise it,” but rather: what is it signaling? what is regulating it? are the symptoms consistent and specific?

The goal here is to build a realistic framework: regulation of the axis, reading symptoms, interpreting tests, and the boundary between physiology and therapy.

The architecture of the HPG axis: how the body decides how much androgenization it can afford

Testosterone does not “exist” on its own: it is the visible output of a control circuit. The hypothalamic–pituitary–gonadal (HPG) axis works in a pulsatile and hierarchical way: the hypothalamus releases GnRH in pulses; the pituitary responds with LH and FSH; the testes translate those signals into testosterone production (Leydig cells) and support for spermatogenesis (Sertoli cells). Pulsatility is not a detail: it is a way of maintaining receptor sensitivity and effective communication. When the central signal flattens out (chronic stress, illness, some therapies, hyperprolactinemia), peripheral output tends to decrease.

The system is restrained by negative feedback. Testosterone and estradiol (derived from aromatization) signal to the brain that androgenization is sufficient. Prolactin, when elevated, can also interfere with the axis. In addition, stress, via the HPA axis (cortisol), can modulate the HPG axis: not always as a total “shut everything down,” but often as a reallocation of biological priorities when the body perceives energy costs or systemic threats.

Then there is the issue that confuses most people: transport and availability. In circulation, testosterone is: - partly bound to SHBG (sex hormone-binding globulin), a fraction that is poorly available to tissues; - partly bound to albumin, a more labile bond; - partly free.

This is why “total” testosterone can tell a different story from biologically available testosterone. If SHBG is high, total testosterone may appear acceptable while free testosterone is low; if SHBG is low (often in obesity/insulin resistance), total testosterone may appear low but free testosterone may be relatively preserved.

Finally, testosterone is also a precursor: in tissues it can become DHT (via 5-alpha-reductase) or estradiol (via aromatase). DHT plays a more prominent role in the prostate and hair follicles; estradiol is central for bone and feedback. This is one of the reasons why reducing everything to “high/low testosterone” is a simplification that loses clinical information.

And all of this happens within a rhythm: testosterone tends to have a morning peak, more evident in younger men, more blunted with age and fragmented sleep. A single blood draw can be misleading not because “labs get it wrong,” but because the system is dynamic.

Components of the androgen system and what they represent

When symptoms lie: libido, energy, mood, and body composition as non-specific signals

The most common clinical tension is this: a person experiences a decline in functioning (fatigue, less motivation, less desire) and looks for a single cause. Testosterone becomes a perfect candidate because it is measurable, debatable, and culturally charged. But many of the symptoms attributed to testosterone have low specificity. In other words: they may be present with low testosterone, but also with normal testosterone; and they may improve without touching the androgen axis if the real cause is corrected.

Libido and erection rarely overlap. Sexual desire has an endocrine component, but also a relational, psychological, and dopaminergic one. Erectile function depends heavily on vascularization, nitric oxide, endothelial health, metabolism, sleep quality, and performance anxiety; medications (for example SSRIs), alcohol, and sedentary behavior can matter more than expected. In many cases testosterone acts as a permissive factor: below a certain threshold it can become limiting, but above that threshold it does not “increase linearly” desire or erection quality.

Energy and “drive” are even more elusive. Low testosterone can be: - an effect of insufficient or fragmented sleep, - a signal of obstructive sleep apnea (OSA), - a marker of inflammation, anemia, hypothyroidism, - or part of a depressive picture.

Here the risk is interpreting as hormonal deficiency what is, in reality, a problem of recovery, nighttime breathing, or chronic psychobiological load. Not because “the mind creates everything,” but because the endocrine system responds to priorities: if the organism is in conservation mode, reproductive function and some androgen-dependent features may be scaled down.

Body composition: visceral adiposity increases aromatization and low-grade inflammation; it can reduce SHBG and alter interpretation of total testosterone; it can feed insulin resistance and a vicious cycle. But beware of assigning a single causal direction: in many people low testosterone is more a marker of metabolic dysfunction than its main driver.

Fertility: this is a chapter of its own. A man can have “acceptable” testosterone and reduced fertility, or vice versa. And above all: introducing exogenous testosterone can suppress LH/FSH and reduce spermatogenesis. So “feeling better” and “having children” may require different strategies.

Mini-framework for a mature reading of symptoms:

• Low libido → common alternatives: stress, relationship conflict, depression, SSRIs/alcohol, OSA → evaluate the hormonal axis if persistent, associated with other androgen-dependent signs, or with endocrine risk factors
• Erectile dysfunction → alternatives: cardiovascular/metabolic risk, smoking, sedentary behavior, anxiety → evaluate metabolism and vascular health first; hormonal axis if desire is reduced and hypogonadism is suspected
• Fatigue/brain fog → alternatives: sleep, anemia, thyroid, inflammation, depression → evaluate systemic causes first; testosterone as part of a panel
• Increased fat/abdominal fat → alternatives: energy balance, insulin resistance, alcohol, sedentary behavior → evaluate metabolically; hormones if the picture is consistent and persistent

The point is not to “rule out testosterone,” but to prevent it from becoming a diagnostic container for everything non-specific.

Tests: what to measure, when to measure it, and how not to be misled by the numbers

In endocrinology, a number only makes sense within a protocol. A diagnosis of hypogonadism is not based on a single “low” blood draw interpreted in isolation, nor on vague symptoms without temporal consistency. It requires repetition, timing, and context.

When to measure: ideally in the morning, under comparable conditions, especially in younger men (where circadian rhythm is more marked). Insufficient sleep in the previous days, recent illness, caloric deficit, alcohol, very intense training, or acute stress can temporarily lower values. A single value can therefore create false alarms or false reassurance. The most cautious practice is to repeat at least twice and interpret the trajectory.

What to measure: total testosterone is often the first step, but it quickly becomes incomplete if SHBG is not included. When SHBG is altered, total testosterone may not represent availability. In these cases, a calculated free testosterone (with SHBG and albumin) is useful when appropriate. It is also important to recognize the limits of methods: some direct “free” measurements may be less reliable; this does not invalidate the concept, but it does require caution.

LH and FSH are often the real interpretive hinge: they help distinguish between a primary (testicular) problem and a secondary (central/functional) one. This is not an academic distinction: it changes the search for causes (testicular damage vs stress, hyperprolactinemia, pituitary disorders, medications) and it changes clinical strategy.

Estradiol and prolactin make sense when the picture requires them: gynecomastia, low libido with testosterone not clearly low, suspicion of medication effects, or neuroendocrine symptoms. Elevated prolactin in particular should not be treated as an “interesting data point”: it can be a powerful modulator of the HPG axis and, in some cases, a signal that deserves structured medical evaluation.

Frequent confounding factors: - Obesity/insulin resistance: often low SHBG → low total with free not necessarily low. - Hyperthyroidism: high SHBG → high/normal total with potentially lower free. - Liver disease, HIV, and some therapies: alter SHBG and hormone metabolism. - Opioids and glucocorticoids: can depress the central axis.

Laboratory patterns and plausible interpretation

These tables do not replace clinical judgment. They are meant to reduce the most common error: reading testosterone as an isolated datum instead of as a window into a system.

Why testosterone can drop: adaptations, pathologies, and the crucial distinction between cause and compensation

A drop in testosterone can be a primary pathology, a central problem, or an adaptation. Confusing these categories leads to inappropriate interventions. The most important point, often overlooked, is distinguishing cause from compensation: in many contexts testosterone falls because the body is containing costs, not because it has “broken down.”

Transient/adaptive decline: acute illness, overreaching, prolonged caloric restriction, psychosocial stress. In these conditions the body may “save” on reproductive function and part of androgen signaling. Treating an adaptation as a primary deficiency means ignoring the signal: it is like turning up the volume so you do not have to listen to the content.

Sleep: this is one of the most robust determinants. Reduced duration, fragmentation, night shifts, and social jet lag alter production. OSA is particularly relevant: intermittent hypoxia and micro-awakenings can depress the axis and worsen metabolism and blood pressure. It is a common cause, often underdiagnosed, and has implications that go far beyond testosterone.

Adiposity and metabolic syndrome: low-grade inflammation, leptin alterations, and insulin resistance interact with the axis. Increased aromatase in adipose tissue can raise estradiol and negative feedback. But the most useful clinical point is pragmatic: in many people, improving body composition and metabolic health also improves the androgen profile without direct hormonal interventions.

Drugs and substances: opioids and glucocorticoids are classic axis suppressors; some psychiatric medications act indirectly (also via prolactin). Alcohol can interfere with sleep, liver function, metabolism, and therefore hormonal balance. As for cannabis use, the evidence is mixed and dose/context-dependent: it is an area where certainty is often oversold.

Anabolic steroids and post-cycle “crash”: here the problem is not only “low values,” but axis suppression and variability in recovery. This is a chapter that requires medical management, not self-treatment.

Endocrine and systemic diseases: hypothyroidism and hyperprolactinemia are relatively common and treatable examples. Hemochromatosis, kidney/liver failure, and some chronic inflammatory conditions can reduce androgen output. Some signals (new and intense headache, visual disturbances, galactorrhea) require prompt medical evaluation: not out of alarmism, but for diagnostic accuracy.

Age: on average levels tend to decline, but variability is large. Often what we attribute to age is the sum of worse sleep, more adiposity, more medications, and more inflammation. Age is not a diagnosis: it is a context in which probability changes.

A useful, non-moralistic lens: testosterone is often an indicator of how much “reproductive and maintenance energy cost” the organism feels able to sustain. In certain conditions, reducing it is an adaptation. The clinical question becomes: is this a reversible adaptation or a persistent deficiency?.

Interventions: first the physiological ecology, then (if needed) therapy—with criteria and caution

The most common risk is not “doing nothing,” but doing the wrong thing too early. A Crionlab approach aims to reduce intervention anxiety: first work on the physiological ecology (sleep, nighttime breathing, metabolism, stress, medications), then — if the picture remains consistent — evaluate therapy in a clinically rigorous way.

Sleep and rhythm: not as a performative ritual, but as an endocrine prerequisite. Regular schedules, sufficient duration, morning light, reduced fragmentation. If OSA is suspected (significant snoring, daytime sleepiness, waking up gasping), the priority is diagnostic and therapeutic: this is not an “optimization” intervention, but correction of a dysfunction with cardiovascular and metabolic consequences.

Training and energy balance: strength and lean mass support metabolic health. But the idea that “training raises testosterone” dramatically is often an oversimplification: training mainly improves insulin sensitivity, inflammation, and body composition, which in turn make the axis more stable. Excessive volume or chronic caloric deficit can instead push toward a downward adaptation. The useful question is: am I building resilience or imposing a cost the body cannot recover from?

Clinical management of causes: treating OSA, reviewing medications when possible with a physician, correcting hypothyroidism or hyperprolactinemia, intervening on metabolic syndrome. Often this is where the highest-leverage part of the work happens, even when the perceived goal was hormonal.

When to consider replacement therapy (TRT): generally, when there are both consistent symptoms, persistently low values on repeated measurements, and reversible causes have already been addressed or excluded. TRT is not a supplement: it requires supervision, follow-up, and monitoring of parameters such as hematocrit, blood pressure, lipids, and, depending on age/risk, PSA and prostate health. Caution here is not moralism: it is management of trade-offs.

Fertility: this is a non-negotiable boundary. Exogenous testosterone can suppress LH/FSH and reduce spermatogenesis. If fertility is a present or future goal, this must be clarified first. There are alternative medical options to discuss with a specialist; but they should not be treated as autonomous “equivalent” shortcuts.

Nutrients and supplements (secondary): these mainly make sense when they correct deficiencies or insufficiencies. Vitamin D if deficient, zinc or magnesium if insufficient: useful as basics, with often modest effects on testosterone if levels are already adequate. The problem with “boosters” is almost always narrative: they promise simple control over a system that is not simple. If the broader framework of how oxidative stress and inflammation interact with physiology is of interest, a useful reference (without turning it into marketing) is: Astaxanthin and protection from oxidative stress: what it can (and cannot) do in human physiology.

Using this article as a framework of questions for a well-structured consultation is more useful than using it as a self-diagnosis tool: what am I measuring, under what conditions, and what am I ruling out?

Beyond the myth of “higher is better”: risks, non-responders, and the ethics of a non-anxiety-producing medicine

The final paradox is that chasing numbers can worsen health. Not because of an abstract principle, but because of a practical fact: a hormone is a regulator within a network. Pushing it upward without a clear clinical reason can shift risks without really shifting the function one hoped to improve.

Overtreatment often arises from two errors: (1) mistaking non-specific symptoms for hypogonadism; (2) reading an isolated value without considering SHBG, timing, sleep, and repetition. The concrete risks are not theoretical: high hematocrit (requiring monitoring), worsening acne or alopecia in predisposed individuals, possible worsening or unmasking of OSA, suppression of fertility. Even when everything is managed correctly, individual variability remains: there is no guaranteed outcome.

There are non-responders in both a clinical and human sense: - men with “low” values who function well: receptor sensitivity, SHBG profile, individual adaptations, and a favorable life context can make the number less decisive; - men with values “within range” who feel unwell: depression, anxiety, inflammation, sedentary behavior, metabolic syndrome, medications, stress, and poor sleep can produce the same lived experience, with testosterone not being the main lever.

There is also a psychological level, often invisible: testosterone as a narrative of control. When life loses coherence (unstable sleep, strained relationships, draining work, a changing body), a biological value seems to offer a fixed point. But it can also become a form of medicalization of unease: if I “fix the hormone,” I do not have to look at the system that made it fragile. It is an understandable risk, not a fault.

The synthesis, if we want an adult sentence, is this: testosterone is part of a system of biological priorities. Often the useful work is not to “raise it,” but to reduce friction: sleep and nighttime breathing, inflammation and metabolic health, stress load, medication review when possible. If after this a consistent picture of hypogonadism remains, therapy may be reasonable — not as a promise, but as a monitored clinical choice.

More precision, less mythology: that is how medicine reduces anxiety instead of producing it.

FAQ

What is the difference between total testosterone and free testosterone?
Total testosterone includes the fraction bound to SHBG and albumin, in addition to the unbound fraction. “Free” testosterone (measured or more often calculated) represents the fraction biologically available to tissues. When SHBG is high or low, total testosterone may be a poor reflection of actual availability.

If I have symptoms but testosterone is “within range,” could I still have an androgen-related problem?
It is possible, but it is not the most likely explanation. Symptoms (fatigue, reduced desire, low mood) are often driven by sleep, stress, depression, medications, metabolic health, or sleep apnea. In some cases SHBG alters the free fraction, or repeated measurements and a more complete panel (LH/FSH, prolactin, estradiol) are needed to frame the picture.

Does testosterone always decline with age?
On average it tends to decrease, but individual variability is large. Body composition, sleep quality, chronic disease, and inflammation often explain more than age itself. That is why “age” is not a diagnosis: one must distinguish physiological decline, reversible causes, and persistent hypogonadism.

Why is a morning blood draw important?
Testosterone follows a circadian rhythm with higher values in the morning and lower ones in the late afternoon/evening. In addition, fragmented or insufficient sleep can lower production. Measuring at different times each time makes results difficult to compare and can create false alarms.

Can testosterone therapy affect fertility?
Yes. Exogenous testosterone can reduce LH and FSH and suppress spermatogenesis, sometimes significantly. If fertility is a present or future goal, this should be discussed first with a specialist to evaluate alternatives and monitoring strategies.

Who might not “respond” to an increase in testosterone with an improvement in symptoms?
People whose symptoms are mainly driven by other causes: depression or anxiety, poor sleep or OSA, alcohol misuse, relationship problems, sedentary behavior, metabolic syndrome, or medication side effects. In these cases, intervening on the number without correcting the context often produces disappointment or side effects without real benefit.

Do vitamin D, zinc, or magnesium really increase testosterone?
In general they mainly help when they correct a deficiency. In individuals with adequate levels, the effect on testosterone is often small or absent. It is more useful to think of these nutrients as foundational support (bone health, neuromuscular function, immune regulation) than as tools to “raise” a hormone.